Skin cancer in a private practice in Sao Paulo City, Brazil;Cancer de pele em clinica particular em Sao Paulo - SP

Anais Brasileiros de Dermatologia

Volumn 71, Issue 6, 1996, Pages 471-476

  Castro, Luiz Guilherme M ^a,b   Freire, Maria Amélia ^c   Toyama, Carmen L ^a   De Britto, Thales F ^a   Gomes, Ana Paula ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

^c NONE

Author keywords

carcinoma, basal cell; carcinoma, squamous cell; melanoma; skin neoplasms

Indexed keywords

ADULT; ARTICLE; BASAL CELL CARCINOMA; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MYCOSIS FUNGOIDES; PRIVATE PRACTICE; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

EID: 12644270233     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Marks R. An overview of skin cancers. Incidence and causation. Cancer 1995;15:75(Suppl. 2):607-12.
2. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 1989;262:2097-100.
3. Gallagher PR, Hill GB, Bajdik CD et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. Arch Dermatol 1995;131:157-69.
4. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30 (5 Pt 1):774-8.
5. Scotto J, Fearst R, Fraumeni JF. Incidence of nonmelanoma skin cancer in the United States. NIH Publication # 83-2433. Washington, DC: US Department of Health and Human Services, 1983.
6. Brumini R, Torloni H, Grötlieb SLD et al. Câncer no Brasil: dados histopatológicos = cancer in Brazil: histopathology data 1976-80. Rio de Janeiro: Campanha Nacional de Combate ao Câncer, Ministério da Saúde, 1982.
7. Brasil. Ministério da Saúde. Instituto Nacional Câncer, Coordenação de Programas de Controle de Cancer - Pro-Onco. Registro Nacional de Patologia Tumoral. Diagnósticos de câncer, Brasil, 1986-90. Rio de Janeiro: Pro-Onco, 1993.
8. Brumini R, Camargo AM. Human topography for oncology (ONCOTOP): a proposal. São Paulo: Stare Health Secretariat. CADAIS - CEBRETAP. 1992
9. Robinson JK. Risk of developing another basal cell carcinoma. Cancer 1987;60:118-20.
10. Schreiber MM, Moon Te, Fox SH, Davidson J. The risk of developing subsequent non melanoma skin cancers. J Am Acad Dermatol 1990;23:1114-8.
11. Epstein E. Value of follow-up after treatment of basal cell carcinoma. Arch Dermatol 1973;108:798-800.
12. Dzubow L, Grossman D. Squamous cell carcinoma and verrucous carcinoma. In: Friedman RJ, Rigel DS, Kopf AW, Harris MN, Baker D. Cancer of the Skin. Philadelphia: Saunders, 1991.
13. Kwa RE, Campana K, Moy RL. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1982;26:1-26.
14. Johnson TM, Smith II JW, Nelson BR, Chang A. Curent therapy for cutaneous melanoma. J Am Acad Dermatol 1995; 32:689-707.
15. Beahrs OH, Henson DE, Hutter RVP et al. eds. Malignant melanoma of the skin. American Joint Committee on Cancer. Manual for staging of cancer. 4th ed. Philadelphia: Lippincot, 1992:143-8.